BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6274512)

  • 1. Expression of human fetal brain antigens by human tumors of neuroectodermal origin as defined by monoclonal antibodies.
    Wikstrand CJ; Bigner DD
    Cancer Res; 1982 Jan; 42(1):267-75. PubMed ID: 6274512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human fetal brain antigen expression common to tumors of neuroectodermal tissue origin.
    Wikstrand CJ; Bourdon MA; Pegram CN; Bigner DD
    J Neuroimmunol; 1982 Aug; 3(1):43-62. PubMed ID: 6284796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common neuroectodermal antigens on human melanoma, neuroblastoma, retinoblastoma, glioblastoma and fetal brain revealed by hybridoma antibodies raised against melanoma cells.
    Liao SK; Clarke BJ; Kwong PC; Brickenden A; Gallic BL; Dent PB
    Eur J Immunol; 1981 Jun; 11(6):450-4. PubMed ID: 7262181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human glioma-mesenchymal extracellular matrix antigen defined by monoclonal antibody.
    Bourdon MA; Wikstrand CJ; Furthmayr H; Matthews TJ; Bigner DD
    Cancer Res; 1983 Jun; 43(6):2796-805. PubMed ID: 6342760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of three restricted specificity monoclonal antibodies raised against the human glioma cell line D-54 MG.
    Wikstrand CJ; Bigner SH; Bigner DD
    J Neuroimmunol; 1984 Jun; 6(3):169-86. PubMed ID: 6373821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production and characterization of two human glioma xenograft-localizing monoclonal antibodies.
    Wikstrand CJ; McLendon RE; Bullard DE; Fredman P; Svennerholm L; Bigner DD
    Cancer Res; 1986 Nov; 46(11):5933-40. PubMed ID: 3756930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human glioma-associated antigens detected by monoclonal antibodies.
    Schnegg JF; Diserens AC; Carrel S; Accolla RS; de Tribolet N
    Cancer Res; 1981 Mar; 41(3):1209-13. PubMed ID: 7459861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential antigenic expression of the DBA/2 lymphoma L1210 and its sublines: cross-reactivity with C3H mammary tumors as defined by syngeneic monoclonal antibodies.
    Rapp L; Fuji H
    Cancer Res; 1983 Jun; 43(6):2592-9. PubMed ID: 6342755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibodies to human prostate and bladder tumor-associated antigens.
    Starling JJ; Sieg SM; Beckett ML; Schellhammer PF; Ladaga LE; Wright GL
    Cancer Res; 1982 Aug; 42(8):3084-9. PubMed ID: 7046915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of human small cell lung cancer differentiation antigens using a panel of rat monoclonal antibodies.
    Rosen ST; Mulshine JL; Cuttitta F; Fedorko J; Carney DN; Gazdar AF; Minna JD
    Cancer Res; 1984 May; 44(5):2052-61. PubMed ID: 6713399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoclonal antibodies to human lung tumor antigens demonstrated by immunofluorescence and immunoprecipitation.
    Brenner BG; Jothy S; Shuster J; Fuks A
    Cancer Res; 1982 Aug; 42(8):3187-92. PubMed ID: 7046919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Detection of surface antigens in uveal melanoma using monoclonal antibodies].
    Cernák A; Kalafut F; Kusenda J; Novotná L
    Cesk Oftalmol; 1989 May; 45(3):145-52. PubMed ID: 2743434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a human cancer-associated antigen defined with monoclonal antibody.
    Bhattacharya M; Chatterjee SK; Barlow JJ
    Cancer Res; 1984 Oct; 44(10):4528-34. PubMed ID: 6380708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of human osteosarcoma-associated antigen(s) by monoclonal antibodies.
    Hosoi S; Nakamura T; Higashi S; Yamamuro T; Toyama S; Shinomiya K; Mikawa H
    Cancer Res; 1982 Feb; 42(2):654-9. PubMed ID: 6173116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
    Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
    Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression by human neuroblastoma cells of an antigen recognized by naturally occurring mouse anti-brain autoantibody.
    Martin SE; Martin WJ
    Cancer Res; 1975 Sep; 35(9):2609-12. PubMed ID: 1149052
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
    Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
    J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of complex antigenic heterogeneity in a human glioma cell line and eight derived clones by specific monoclonal antibodies.
    Wikstrand CJ; Bigner SH; Bigner DD
    Cancer Res; 1983 Jul; 43(7):3327-34. PubMed ID: 6303581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monoclonal antibodies against cell surface antigens present on human urinary bladder cancer cells.
    Masuko T; Yagita H; Hashimoto Y
    J Natl Cancer Inst; 1984 Mar; 72(3):523-30. PubMed ID: 6583438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumors.
    de Muralt B; de Tribolet N; Diserens AC; Carrel S; Mach JP
    Anticancer Res; 1983; 3(1):1-6. PubMed ID: 6830147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.